Brand Name | Status | Last Update |
---|---|---|
ontralfy | New Drug Application | 2024-12-20 |
tizanidine | ANDA | 2025-05-27 |
tizanidine hcl | ANDA | 2024-12-31 |
tizanidine hydrochloride | ANDA | 2025-05-16 |
zanaflex | New Drug Application | 2025-05-05 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | 1 | — | — | — | — | 1 |
Drug common name | Tizanidine |
INN | tizanidine |
Description | Tizanidine is 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites. It has a role as an alpha-adrenergic agonist and a muscle relaxant. It is a benzothiadiazole and a member of imidazoles. |
Classification | Small molecule |
Drug class | α2-adrenergic receptor agonist |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Clc1ccc2nsnc2c1NC1=NCCN1 |
PDB | — |
CAS-ID | 51322-75-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1079 |
ChEBI ID | 63629 |
PubChem CID | 5487 |
DrugBank | DB00697 |
UNII ID | 6AI06C00GW (ChemIDplus, GSRS) |